Literature DB >> 19005183

CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression.

Yixin Tang1, Elizabeth A Scheef, Shoujian Wang, Christine M Sorenson, Craig B Marcus, Colin R Jefcoate, Nader Sheibani.   

Abstract

Reactive species derived from cell oxygenation processes play an important role in vascular homeostasis and the pathogenesis of many diseases including retinopathy of prematurity. We show that CYP1B1-deficient (CYP1B1(-/-)) mice fail to elicit a neovascular response during oxygen-induced ischemic retinopathy. In addition, the retinal endothelial cells (ECs) prepared from CYP1B1(-/-) mice are less adherent, less migratory, and fail to undergo capillary morphogenesis. These aberrant cellular responses were completely reversed when oxygen levels were lowered or an antioxidant added. CYP1B1(-/-) ECs exhibited increased oxidative stress and expressed increased amounts of the antiangiogenic factor thrombospondin-2 (TSP2). Increased lipid peroxidation and TSP2 were both observed in retinas from CYP1B1(-/-) mice and were reversed by administration of an antioxidant. Reexpression of CYP1B1 in CYP1B1(-/-) ECs resulted in down-regulation of TSP2 expression and restoration of capillary morphogenesis. A TSP2 knockdown in CYP1B1(-/-) ECs also restored capillary morphogenesis. Thus, CYP1B1 metabolizes cell products that modulate intracellular oxidative stress, which enhances production of TSP2, an inhibitor of EC migration and capillary morphogenesis. Evidence is presented that similar changes occur in retinal endothelium in vivo to limit neovascularization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005183      PMCID: PMC2628380          DOI: 10.1182/blood-2008-03-145219

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  59 in total

1.  Cytochrome P-450 under pressure: more evidence for a link between 20-hydroxyeicosatetraenoic acid and hypertension.

Authors:  Ingrid Fleming
Journal:  Circulation       Date:  2005-01-04       Impact factor: 29.690

Review 2.  Cytochrome P450: nature's most versatile biological catalyst.

Authors:  Minor J Coon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

3.  Differentiation of pluripotent C3H10T1/2 cells rapidly elevates CYP1B1 through a novel process that overcomes a loss of Ah Receptor.

Authors:  Young C Cho; Wenchao Zheng; Megumi Yamamoto; Xiequing Liu; Paul R Hanlon; Colin R Jefcoate
Journal:  Arch Biochem Biophys       Date:  2005-07-15       Impact factor: 4.013

4.  Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

Authors:  Mohamed Al-Shabrawey; Manuela Bartoli; Azza B El-Remessy; Daniel H Platt; Sue Matragoon; M Ali Behzadian; Robert W Caldwell; Ruth B Caldwell
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

Authors:  J Lawler; M Sunday; V Thibert; M Duquette; E L George; H Rayburn; R O Hynes
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.

Authors:  J T Buters; S Sakai; T Richter; T Pineau; D L Alexander; U Savas; J Doehmer; J M Ward; C R Jefcoate; F J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Inhibitors of cytochrome P450 4A suppress angiogenic responses.

Authors:  Ping Chen; Meng Guo; Dana Wygle; Paul A Edwards; John R Falck; Richard J Roman; A Guillermo Scicli
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 8.  Anterior segment development relevant to glaucoma.

Authors:  Douglas B Gould; Richard S Smith; Simon W M John
Journal:  Int J Dev Biol       Date:  2004       Impact factor: 2.203

Review 9.  Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase.

Authors:  Masuko Ushio-Fukai; R Wayne Alexander
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

10.  Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis.

Authors:  T R Kyriakides; Y H Zhu; L T Smith; S D Bain; Z Yang; M T Lin; K G Danielson; R V Iozzo; M LaMarca; C E McKinney; E I Ginns; P Bornstein
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

View more
  64 in total

1.  Opposing effects of bim and bcl-2 on lung endothelial cell migration.

Authors:  Cathy Grutzmacher; SunYoung Park; Tammy L Elmergreen; Yixin Tang; Elizabeth A Scheef; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-23       Impact factor: 5.464

Review 2.  Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.

Authors:  Andreas Stahl; Tim U Krohne; Przemyslaw Sapieha; Jing Chen; Ann Hellstrom; Emily Chew; Frank G Holz; Lois E H Smith
Journal:  Br J Ophthalmol       Date:  2011-03-18       Impact factor: 4.638

3.  CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress.

Authors:  Yixin Tang; Elizabeth A Scheef; Zafer Gurel; Christine M Sorenson; Colin R Jefcoate; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-23       Impact factor: 4.249

4.  CYP1B1 deficiency ameliorates obesity and glucose intolerance induced by high fat diet in adult C57BL/6J mice.

Authors:  Xiaocong Liu; Tingting Huang; Lu Li; Yumeng Tang; Yatao Tian; Suqing Wang; Cuifang Fan
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

5.  Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2.

Authors:  Susan MacLauchlan; Jun Yu; Marcus Parrish; Tara A Asoulin; Michael Schleicher; Marie M Krady; Jianmin Zeng; Paul L Huang; William C Sessa; Themis R Kyriakides
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

6.  Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation.

Authors:  Fariborz A Yaghini; Chi Young Song; Eduard N Lavrentyev; Hafiz U B Ghafoor; Xiao R Fang; Anne M Estes; William B Campbell; Kafait U Malik
Journal:  Hypertension       Date:  2010-05-03       Impact factor: 10.190

Review 7.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

Review 8.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

9.  Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.

Authors:  Cathy Grutzmacher; SunYoung Park; Yun Zhao; Margaret E Morrison; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-17

10.  The role of thrombospondins in wound healing, ischemia, and the foreign body reaction.

Authors:  Themis R Kyriakides; Susan Maclauchlan
Journal:  J Cell Commun Signal       Date:  2009-10-21       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.